Top
Best
New

Posted by worik 2 days ago

FDA advisors unanimously vote to approve Moderna's mRNA after agency drama(arstechnica.com)
235 points | 139 commentspage 3
linuxftw 1 day ago|
More deaths in the new study group for this product. More overall adverse reactions for the new product.

Here's the top-line comparison:

Healthcare encounter:

new: 80 (0.4)

existing: 120 (0.6)

Each group had roughly 20k participants, mostly white.

No actual control group, no independent third party study. Junk.

s1artibartfast 1 day ago|
What is the baseline?
chmorgan_ 1 day ago|
If Prasad thought this needed more research then it needed more research. He and the people he works with have written dozens, maybe hundreds now, of reports that expose studies that lack the rigor for definitive results, have misleading endpoints, have imbalanced arms etc. I get that anything that would slow vaccines down has somehow become political and lots of people would gladly accept the pharmaceutical companies word on things. This is a blindness due to political leanings and not evidence based. If Prasad says it needs more and better data I'd put money on it needing it.
kelnos 1 day ago|
> This is a blindness due to political leanings and not evidence based.

Your comment reeks of that as well.